Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term E0302 Study in ALS
NCT00445172Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2008
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of mecobalamin in amyotrophic lateral sclerosis (ALS), sponsored by Eisai Co., Ltd.. Started Feb 2008; status: completed.
02
Drugs
mecobalamin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00445172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445172.